StockData
Exelixis, Inc. logo

Exelixis, Inc. (EXEL) stock

EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 18/303% above fair value
$68.29−0.21 (-0.31%)

Close on Nov 18, 2026Market cap $16.66BP/E 20.4Yield –

Exelixis market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Exelixis's market cap was $17.60B on Nov 11, 2026, against $11.84B a year earlier. Over the last 5 years it ranged from $5.05B to $17.60B, with a median of $7.23B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$17.60B+49.7%
2025Dec 31, 2025$11.75B+23.5%
2024Dec 31, 2024$9.52B+27.6%
2023Dec 29, 2023$7.46B+44.2%
2022Dec 30, 2022$5.17B-10.5%
2021Dec 31, 2021$5.78B-6.9%
2020Dec 31, 2020$6.21B+16.0%
2019Dec 31, 2019$5.35B-9.0%
2018Dec 31, 2018$5.88B-34.6%
2017Dec 29, 2017$8.99B+110.7%
2016Dec 30, 2016$4.27B+234.5%
2015Dec 31, 2015$1.28B+353.8%
2014Dec 31, 2014$281.06M-75.1%
2013Dec 31, 2013$1.13B+34.7%
2012Dec 31, 2012$838.54M-0.4%
2011Jul 29, 2011$841.51M-4.3%
2010Dec 31, 2010$879.07M–

More Exelixis figures

See a number that looks wrong?